Although the virus is typically a mild childhood illness that peaks in the summer and early fall, this year it is appearing ...

Key market opportunities in the India Ciprofloxacin market include addressing the high demand driven by widespread bacterial ...

The respiratory syncytial virus vaccine is effective in reducing emergency visits, hospitalizations, and severe illness in ...

Clinicians must adapt to the new reality of HFMD, as emerging strains drive serious complications and challenge old ...

Continuous renal replacement therapy is designed to function similarly to natural kidneys by continuously removing waste ...

Measles cases in the United States hit a 33-year high in 2025. And with cases reported in 42 states, many clinicians are ...

As respiratory virus season begins, pediatric experts are preparing for an expected rise in cases of Respiratory Syncytial ...

In June 2024, EPKINLY monotherapy was granted accelerated approval by the FDA for the treatment of R/R FL following two or more lines of systemic therapy. With the results from the confirmatory Phase ...

To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report ...

The following highlights spotlight the latest advances in gastroenterology, featuring studies and insights presented at this ...

NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...